PATRICIA MURDOCH: Open Payments
NPI 1932279742 · GALES FERRY, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$935 in 39 payments from 18 companies in 2025. Trend: 2023 $285 · 2024 $1,319 · 2025 $935
Food & beverage: $935
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $155 |
| Lilly USA, LLC | 4 | $123 |
| GlaxoSmithKline, LLC. | 4 | $98 |
| Astellas Pharma US Inc | 3 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $78 |
| ABBVIE INC. | 3 | $57 |
| PFIZER INC. | 2 | $48 |
| Amgen Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
| Baxter Healthcare | 1 | $33 |
Products named: JARDIANCE, Veozah, Rybelsus, MOUNJARO, VRAYLAR, Ozempic, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across CT — which companies pay providers there.
